CClinicalTrials.gg
Status unknownNCT04623853Updated Apr 18, 2023

Investigating Auto Adjusting Dynamic AFO

An interventional study of Variable Stiffness AFO in Lower Limb; Fusion, Congenital, Lower Limb Fracture and Ankle Foot Injury, sponsored by University of Washington. Status unknown at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-04-18.

Sponsored by University of Washington · Not applicable, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified Apr 2023), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
22
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Offloading Ankle Foot Orthoses (AFOs) are devices designed for people following lower-limb reconstruction to restore mobility by reducing mechanical loading through the injury site and redistributing it proximally. While they perform well for some users, their current form limits full functional potential and may put joints proximal to the injury at risk of long-term damage. This study is directed toward designing and testing a lightweight, variable stiffness, dynamic brace that can adjust in response to user activity.

02

Conditions studied

  • Lower Limb; Fusion, Congenital
  • Lower Limb Fracture
  • Ankle Foot Injury

Browse trials for

Keywords

  • Ankle foot orthotic
03

In context

Foot Injuries

51 studies on the registry are indexed under Foot Injuries; 10 are open to participants now.

This study's planned enrollment of 22 is below the median of 52 across 38 interventional studies indexed under Foot Injuries.

Browse Foot Injuries studies →

Lead sponsor

University of Washington is the lead sponsor of 1,397 studies on the registry; 225 are open to participants now.

Of its 154 completed or terminated interventional studies of FDA-regulated products, 132 (86%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria (Healthy Volunteers):

-able to run continuously for 1 minute

Inclusion Criteria (All Other Volunteers)

  • prescribed an offloading Ankle-Foot Orthosis (AFO) for walking/running
  • Use prescribed offloading AFO at least 20 hours per week
  • Prescribed AFO strut length of at least 200 mm
  • Able to run continuously for 1 minute

Exclusion Criteria (Healthy Volunteers):

  • limited sensation in the lower limbs
  • use an assistive device

Exclusion Criteria (All Other Volunteers):

  • Unable to ambulate (walk/run) continuously with AFO for at least 1 minute
  • Unable to sit, stand, or negotiate a step onto lab treadmill
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
22 participants (estimated)

Study arms

  • Experimental
    Aim 2

    Participants will carry out a protocol comprised of treadmill walking in a laboratory setting while wearing the Dynamic AFO device.

    Device: Variable Stiffness AFO

  • Experimental
    Aim 3

    Participants will be asked to take the Dynamic AFO home and wear the device for up to 4 weeks. The device will be set in either an adjustment-capable mode, or a "locked" mode that functions similar to their own orthotic--the order in which they are tested will be randomized.

    Device: Variable Stiffness AFO

Interventions

  • DeviceVariable Stiffness AFO

    The Dynamic AFO is able to adjust in stiffness depending on activity.

06

What researchers measure

Primary outcomes

  1. Time Running Per Day

    Collected while participant uses device in free-living environment.

    Time frame: Calculated across all days of data collection (up to 4 weeks).

  2. Longest Running Bout Duration

    Collected while participant uses device in free-living environment.

    Time frame: Across all days of data collection (up to 4 weeks), the longest bout of continuous activity will be identified (minutes).

  3. PROMIS-Fatigue

    Participants will be asked to fill out a questionnaire related to their experience using the variable stiffness AFO out of lab in various test configurations. Each PROMIS-Fatigue question asks participants to rank on a scale from 1 to 5 (categorical options), with higher scores indicating a greater level of fatigue.

    Time frame: Following their time out in their free-living environment (up to 4 weeks at a time), participants will be asked to complete a questionnaire related to fatigue.

  4. Pain Score

    Participants will be asked to fill out a questionnaire related to their experience using the variable stiffness AFO out of lab in various test configurations. Each Pain-Score question asks participants to rank on a scale from 1 to 10 (categorical options), with higher scores indicating a greater level of pain.

    Time frame: Following their time out in their free-living environment (up to 4 weeks at a time), participants will be asked to complete a questionnaire related to pain.

  5. Orthotic Evaluation Questionnaire (OEQ)

    Similar to the Prosthesis Evaluation Questionnaire (PEQ), the OEQ will ask various questions concerning their experience wearing the variable stiffness AFO. Participants will rate their overall satisfaction, ability to ambulate, the health of their limb, the utility of the device, and their overall well-being after wearing the device.

    Time frame: Following their time out in their free-living environment (up to 4 weeks at a time), participants will be asked to complete an OEQ.

  6. Running Speed on Treadmill

    Participants carrying out the in-lab protocol will be asked to run using the variable stiffness AFO and running speed will be documented at various time points.

    Time frame: In-lab testing will occur over the course of up to 2 hours at a time.

  7. Extended Figure-of-8 Test

    Participants carrying out the in-lab protocol will be asked to do a Figure-of-8 test.

    Time frame: In-lab testing wil occur over the course of up to 2 hours at a time.

07

Study locations

1 of 1 sites recruiting
  • University of Washington, Dept. of Bioengineering
    Seattle, Washington 98105, United States
    • Daniel Ballesteros · Contact · 206-221-5873
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 18, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04623853
Lead sponsor
University of Washington
Collaborators
United States Department of Defense
Responsible party
Joan Sanders (Professor: Engineering, University of Washington) — Principal investigator
First posted
Nov 10, 2020
Start date
Nov 30, 2020
Primary completion
Sep 30, 2024 (estimated)
Completion
Dec 2024 (estimated)
Last update
Apr 18, 2023

Study contacts

Daniel Ballesteros, BS
Contact
danielb25@uw.edu
206-221-5873
Katheryn Allyn, CPO, LPO
Contact
206-390-0228
Joan E Sanders, PhD
principal investigator · University of Washington

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion